# FDA Inspection 1102778 - Octapharma Plasma, Inc. - August 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/97834b7b-bd71-4521-a095-73fe99711d72
Source feed: FDA_Inspections

> FDA Inspection 1102778 for Octapharma Plasma, Inc. on August 12, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102778
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2019-08-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 988583 - 2016-08-31](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/a6cc8233-a987-42c3-ab25-50b58e355528)
- [FDA Inspection 841994 - 2013-07-26](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/1c32cb36-e479-4497-9f2e-02123309c617)
- [FDA Inspection 552992 - 2008-12-17](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/bd367218-6a8a-4573-b6b3-957783b454ce)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/335eaa66-a2af-4794-9bfd-ef853299a4f2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d